LY2405319

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2013-2018
012320132018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Fibroblast growth factor 21 (FGF21) is an important metabolic regulator expressed predominantly in the liver. In this study, we… (More)
  • figure 1
  • figure 4
Is this relevant?
2016
2016
Non-alcoholic fatty liver disease (NAFLD) is a prevalent obesity-related disease that affects large populations throughout the… (More)
Is this relevant?
2015
2015
AIM To investigate the effects of LY2405319, an analogue of fibroblast growth factor 21 (FGF21), on glucose homeostasis in… (More)
Is this relevant?
2014
2014
Fibroblast growth factor 21 (FGF21) is an endocrine hormone that is critical for regulation of intermediary metabolism, and it is… (More)
  • figure 1
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Fibroblast growth factor 21 (FGF21) is a recently discovered metabolic regulator. Exogenous FGF21 produces beneficial metabolic… (More)
  • figure 1
  • table 1
  • table 2
  • table 2
  • figure 2
Is this relevant?
2013
2013
Fibroblast growth factor 21 (FGF21) is a novel metabolic regulator that represents a promising target for the treatment of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2013
2013
Fibroblast growth factor 21 is a novel hormonal regulator with the potential to treat a broad variety of metabolic abnormalities… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?